Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Journal of the Pediatric Infectious Diseases Society|June 13, 2023
Non-Tuberculous Mycobacterial Cervicofacial Lymphadenitis in Children-10-Year Experience in a Tertiary Pediatric CenterOlivia Leow, Rie Aoyama, Woei Shyang Loh, et al.
Pathology|October 23, 2020
Head-to-head evaluation on diagnostic accuracies of six SARS-CoV-2 serological assaysShaun S Tan, Sharon Saw, Ka Lip Chew, et al.
The Journal of Antimicrobial Chemotherapy|December 18, 2020
In vitro susceptibility of Mycobacterium abscessus complex and feasibility of standardizing treatment regimensKa Lip Chew, Sophie Octavia, Joelle Go, et al.
Annals of Laboratory Medicine|February 10, 2026
Evaluating a Flexible Workflow for <i>Candida auris</i> Surveillance on the AltoStar Automation System AM16 with Commercial and In-House Real-Time PCR AssaysChun Kiat Lee, Janet Weng Sze Cheng, Nur Atiqah Liyana, et al.
Archives of Pathology & Laboratory Medicine|December 28, 2020
Comparative Clinical Evaluation of the Roche Elecsys and Abbott Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Serology Assays for Coronavirus Disease 2019 (COVID-19)Shaun S Tan, Sharon Saw, Ka Lip Chew, et al.
Microbiology Spectrum|November 12, 2025
Epidemiology of diarrheagenic pathogens in acute hospitals in Singapore: a retrospective multicenter studyBryan M H Keng, Pandora Han, Adrian Low, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 19, 2021
Collaborative Equilibrium Coupling of Catalytic DNA Nanostructures Enables Programmable Detection of SARS-CoV-2Yuan Chen, Noah R Sundah, Nicholas R Y Ho, et al.
International Journal of Antimicrobial Agents|December 17, 2019
Outcomes of treating AmpC-producing Enterobacterales bacteraemia with carbapenems vs. non-carbapenemsSock Hoon Tan, Tat Ming Ng, Ka Lip Chew, et al.
Science Advances|March 18, 2021
Catalytic amplification by transition-state molecular switches for direct and sensitive detection of SARS-CoV-2Noah R Sundah, Auginia Natalia, Yu Liu, et al.
The Lancet. Infectious Diseases|March 26, 2023
Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trialGail B Cross, Intan P Sari, Cissy Kityo, et al.
Pageof 6